Artículos de revistas sobre el tema "DNA Ligase Inhibitors"
Crea una cita precisa en los estilos APA, MLA, Chicago, Harvard y otros
Consulte los 50 mejores artículos de revistas para su investigación sobre el tema "DNA Ligase Inhibitors".
Junto a cada fuente en la lista de referencias hay un botón "Agregar a la bibliografía". Pulsa este botón, y generaremos automáticamente la referencia bibliográfica para la obra elegida en el estilo de cita que necesites: APA, MLA, Harvard, Vancouver, Chicago, etc.
También puede descargar el texto completo de la publicación académica en formato pdf y leer en línea su resumen siempre que esté disponible en los metadatos.
Explore artículos de revistas sobre una amplia variedad de disciplinas y organice su bibliografía correctamente.
Alomari, Arqam, Robert Gowland, Callum Southwood, Jak Barrow, Zoe Bentley, Jashel Calvin-Nelson, Alice Kaminski et al. "Identification of Novel Inhibitors of Escherichia coli DNA Ligase (LigA)". Molecules 26, n.º 9 (25 de abril de 2021): 2508. http://dx.doi.org/10.3390/molecules26092508.
Texto completoCiarrocchi, Giovanni, Donald G. MacPhee, Les W. Deady y Leann Tilley. "Specific Inhibition of the Eubacterial DNA Ligase by Arylamino Compounds". Antimicrobial Agents and Chemotherapy 43, n.º 11 (1 de noviembre de 1999): 2766–72. http://dx.doi.org/10.1128/aac.43.11.2766.
Texto completoShapiro, Adam B., Ann E. Eakin, Grant K. Walkup y Olga Rivin. "A High-Throughput Fluorescence Resonance Energy Transfer-Based Assay for DNA Ligase". Journal of Biomolecular Screening 16, n.º 5 (11 de marzo de 2011): 486–93. http://dx.doi.org/10.1177/1087057111398295.
Texto completoHowes, Timothy R. L., Annahita Sallmyr, Rhys Brooks, George E. Greco, Darin E. Jones, Yoshihiro Matsumoto y Alan E. Tomkinson. "Structure-activity relationships among DNA ligase inhibitors: Characterization of a selective uncompetitive DNA ligase I inhibitor". DNA Repair 60 (diciembre de 2017): 29–39. http://dx.doi.org/10.1016/j.dnarep.2017.10.002.
Texto completoTAN, Ghee T., Sangkook LEE, Ik-Soo LEE, Jingwen CHEN, Pete LEITNER, Jeffrey M. BESTERMAN, Douglas A. KINGHORN y John M. PEZZUTO. "Natural-product inhibitors of human DNA ligase I". Biochemical Journal 314, n.º 3 (15 de marzo de 1996): 993–1000. http://dx.doi.org/10.1042/bj3140993.
Texto completoTobin, Lisa A., Aaron P. Rapoport, Ivana Gojo, Maria R. Baer, Alan E. Tomkinson y Feyruz V. Rassool. "DNA Ligase III Alpha and (Poly-ADP) Ribose Polymerase (PARP1) Are Therapeutic Targets in Imatinib-Resistant (IR) Chronic Myeloid Leukemia (CML)." Blood 114, n.º 22 (20 de noviembre de 2009): 853. http://dx.doi.org/10.1182/blood.v114.22.853.853.
Texto completoTomkinson, Alan E., Tasmin Naila y Seema Khattri Bhandari. "Altered DNA ligase activity in human disease". Mutagenesis 35, n.º 1 (20 de octubre de 2019): 51–60. http://dx.doi.org/10.1093/mutage/gez026.
Texto completoMills, Scott D., Ann E. Eakin, Ed T. Buurman, Joseph V. Newman, Ning Gao, Hoan Huynh, Kenneth D. Johnson et al. "Novel Bacterial NAD+-Dependent DNA Ligase Inhibitors with Broad-Spectrum Activity and Antibacterial EfficacyIn Vivo". Antimicrobial Agents and Chemotherapy 55, n.º 3 (28 de diciembre de 2010): 1088–96. http://dx.doi.org/10.1128/aac.01181-10.
Texto completoHowes, Timothy R. L., Annahita Sallmyr, Rhys Brooks, George E. Greco, Darin E. Jones, Yoshihiro Matsumoto y Alan E. Tomkinson. "Erratum to “Structure-activity relationships among DNA ligase inhibitors; characterization of a selective uncompetitive DNA ligase I inhibitor” [DNA Repair 60C (2017) 29–39]". DNA Repair 61 (enero de 2018): 99. http://dx.doi.org/10.1016/j.dnarep.2017.12.001.
Texto completoAndo, Kiyohiro, Yusuke Suenaga y Takehiko Kamijo. "DNA Ligase 4 Contributes to Cell Proliferation against DNA-PK Inhibition in MYCN-Amplified Neuroblastoma IMR32 Cells". International Journal of Molecular Sciences 24, n.º 10 (19 de mayo de 2023): 9012. http://dx.doi.org/10.3390/ijms24109012.
Texto completoSallmyr, Annahita, Lisa Tobin, Alan E. Tomkinson y Feyruz V. Rassool. "Inhibiting Alternative Non Homologus Endjoining (NHEJ) Pathways: Therapeutic Targets in Chronic Myeloid Leukemia (CML)." Blood 112, n.º 11 (16 de noviembre de 2008): 1088. http://dx.doi.org/10.1182/blood.v112.11.1088.1088.
Texto completoMontecucco, A., M. Lestingi, G. Pedrali-Noy, S. Spadari y G. Ciarrocchi. "Use of ATP, dATP and their α-thio derivatives to study DNA ligase adenylation". Biochemical Journal 271, n.º 1 (1 de octubre de 1990): 265–68. http://dx.doi.org/10.1042/bj2710265.
Texto completoGUL, Sheraz, Richard BROWN, Earl MAY, Marie MAZZULLA, Martin G. SMYTH, Colin BERRY, Andrew MORBY y David J. POWELL. "Staphylococcus aureus DNA ligase: characterization of its kinetics of catalysis and development of a high-throughput screening compatible chemiluminescent hybridization protection assay". Biochemical Journal 383, n.º 3 (26 de octubre de 2004): 551–59. http://dx.doi.org/10.1042/bj20040054.
Texto completoChen, Xi, Shijun Zhong, Xiao Zhu, Barbara Dziegielewska, Tom Ellenberger, Gerald M. Wilson, Alexander D. MacKerell y Alan E. Tomkinson. "Rational Design of Human DNA Ligase Inhibitors that Target Cellular DNA Replication and Repair". Cancer Research 68, n.º 9 (1 de mayo de 2008): 3169–77. http://dx.doi.org/10.1158/0008-5472.can-07-6636.
Texto completoBuurman, Ed T., Valerie A. Laganas, Ce Feng Liu y John I. Manchester. "Antimicrobial Activity of Adenine-Based Inhibitors of NAD+-Dependent DNA Ligase". ACS Medicinal Chemistry Letters 3, n.º 8 (16 de julio de 2012): 663–67. http://dx.doi.org/10.1021/ml300169x.
Texto completoHale, Michael R., Claire Brassington, Dan Carcanague, Kevin Embrey, Charles J. Eyermann, Robert A. Giacobbe, Lakshmaiah Gingipalli et al. "From fragments to leads: novel bacterial NAD + -dependent DNA ligase inhibitors". Tetrahedron Letters 56, n.º 23 (junio de 2015): 3108–12. http://dx.doi.org/10.1016/j.tetlet.2014.12.067.
Texto completoShrivastava, Nidhi, Jeetendra K. Nag, Jyoti Pandey, Rama Pati Tripathi, Priyanka Shah, Mohammad Imran Siddiqi y Shailja Misra-Bhattacharya. "Homology Modeling of NAD+-Dependent DNA Ligase of the Wolbachia Endosymbiont of Brugia malayi and Its Drug Target Potential Using Dispiro-Cycloalkanones". Antimicrobial Agents and Chemotherapy 59, n.º 7 (6 de abril de 2015): 3736–47. http://dx.doi.org/10.1128/aac.03449-14.
Texto completoHoward, Steven, Nader Amin, Andrew B. Benowitz, Elisabetta Chiarparin, Haifeng Cui, Xiaodong Deng, Tom D. Heightman et al. "Fragment-Based Discovery of 6-Azaindazoles As Inhibitors of Bacterial DNA Ligase". ACS Medicinal Chemistry Letters 4, n.º 12 (18 de octubre de 2013): 1208–12. http://dx.doi.org/10.1021/ml4003277.
Texto completoSwift, Robert V. y Rommie E. Amaro. "Discovery and design of DNA and RNA ligase inhibitors in infectious microorganisms". Expert Opinion on Drug Discovery 4, n.º 12 (24 de noviembre de 2009): 1281–94. http://dx.doi.org/10.1517/17460440903373617.
Texto completoStokes, Suzanne S., Hoan Huynh, Madhusudhan Gowravaram, Robert Albert, Marta Cavero-Tomas, Brendan Chen, Jenna Harang et al. "Discovery of bacterial NAD+-dependent DNA ligase inhibitors: Optimization of antibacterial activity". Bioorganic & Medicinal Chemistry Letters 21, n.º 15 (agosto de 2011): 4556–60. http://dx.doi.org/10.1016/j.bmcl.2011.05.128.
Texto completoMandalapu, Dhanaraju, Deependra Kumar Singh, Sonal Gupta, Vishal M. Balaramnavar, Mohammad Shafiq, Dibyendu Banerjee y Vishnu Lal Sharma. "Discovery of monocarbonyl curcumin hybrids as a novel class of human DNA ligase I inhibitors: in silico design, synthesis and biology". RSC Advances 6, n.º 31 (2016): 26003–18. http://dx.doi.org/10.1039/c5ra25853g.
Texto completoSun, Daekyu y Rheanna Urrabaz. "Development of non-electrophoretic assay method for DNA ligases and its application to screening of chemical inhibitors of DNA ligase I". Journal of Biochemical and Biophysical Methods 59, n.º 1 (abril de 2004): 49–59. http://dx.doi.org/10.1016/s0165-022x(02)00071-4.
Texto completoJahagirdar, Devashree, Shruti Purohit y Nilesh K. Sharma. "Combinatorial Use of DNA Ligase Inhibitor L189 and Temozolomide Potentiates Cell Growth Arrest in HeLa". Current Cancer Therapy Reviews 15, n.º 1 (22 de febrero de 2019): 65–73. http://dx.doi.org/10.2174/1573394714666180216150332.
Texto completoZhong, Shijun, Xi Chen, Xiao Zhu, Barbara Dziegielewska, Kurtis E. Bachman, Tom Ellenberger, Jeff D. Ballin, Gerald M. Wilson, Alan E. Tomkinson y Alexander D. MacKerell. "Identification and Validation of Human DNA Ligase Inhibitors Using Computer-Aided Drug Design". Journal of Medicinal Chemistry 51, n.º 15 (agosto de 2008): 4553–62. http://dx.doi.org/10.1021/jm8001668.
Texto completoLeckie, Gregor W., Dwight D. Erickson, Qizhi He, Ingrid E. Facey, Bor-Chian Lin, Jianli Cao y Folim G. Halaka. "Method for Reduction of Inhibition in aMycobacterium tuberculosis-Specific Ligase Chain Reaction DNA Amplification Assay". Journal of Clinical Microbiology 36, n.º 3 (1998): 764–67. http://dx.doi.org/10.1128/jcm.36.3.764-767.1998.
Texto completoYi, Lanhua y Xin Lü. "New Strategy on Antimicrobial-resistance: Inhibitors of DNA Replication Enzymes". Current Medicinal Chemistry 26, n.º 10 (20 de junio de 2019): 1761–87. http://dx.doi.org/10.2174/0929867324666171106160326.
Texto completoStokes, Suzanne S., Madhusudhan Gowravaram, Hoan Huynh, Min Lu, George B. Mullen, Brendan Chen, Robert Albert et al. "Discovery of bacterial NAD+-dependent DNA ligase inhibitors: Improvements in clearance of adenosine series". Bioorganic & Medicinal Chemistry Letters 22, n.º 1 (enero de 2012): 85–89. http://dx.doi.org/10.1016/j.bmcl.2011.11.071.
Texto completoSashidhara, Koneni V., L. Ravithej Singh, Mohammad Shameem, Sarika Shakya, Anoop Kumar, Tulsankar Sachin Laxman, Shagun Krishna, Mohammad Imran Siddiqi, Rabi S. Bhatta y Dibyendu Banerjee. "Design, synthesis and anticancer activity of dihydropyrimidinone–semicarbazone hybrids as potential human DNA ligase 1 inhibitors". MedChemComm 7, n.º 12 (2016): 2349–63. http://dx.doi.org/10.1039/c6md00447d.
Texto completoMurphy-Benenato, Kerry E., Lakshmaiah Gingipalli, P. Ann Boriack-Sjodin, Gabriel Martinez-Botella, Dan Carcanague, Charles J. Eyermann, Madhu Gowravaram et al. "Negishi cross-coupling enabled synthesis of novel NAD+-dependent DNA ligase inhibitors and SAR development". Bioorganic & Medicinal Chemistry Letters 25, n.º 22 (noviembre de 2015): 5172–77. http://dx.doi.org/10.1016/j.bmcl.2015.09.075.
Texto completoElder, Rhoderick H. y Daphne J. Osborne. "Function of DNA synthesis and DNA repair in the survival of embryos during early germination and in dormancy". Seed Science Research 3, n.º 1 (marzo de 1993): 43–53. http://dx.doi.org/10.1017/s0960258500001550.
Texto completoGao, Shan-Shan, Hua Guan, Shuang Yan, Sai Hu, Man Song, Zong-Pei Guo, Da-Fei Xie et al. "TIP60 K430 SUMOylation attenuates its interaction with DNA-PKcs in S-phase cells: Facilitating homologous recombination and emerging target for cancer therapy". Science Advances 6, n.º 28 (julio de 2020): eaba7822. http://dx.doi.org/10.1126/sciadv.aba7822.
Texto completoCerqueira, Sofia A., Min Tan, Shijun Li, Franceline Juillard, Colin E. McVey, Kenneth M. Kaye y J. Pedro Simas. "Latency-Associated Nuclear Antigen E3 Ubiquitin Ligase Activity Impacts Gammaherpesvirus-Driven Germinal Center B Cell Proliferation". Journal of Virology 90, n.º 17 (15 de junio de 2016): 7667–83. http://dx.doi.org/10.1128/jvi.00813-16.
Texto completoHayes, Andrew J., Jiulia Satiaputra, Louise M. Sternicki, Ashleigh S. Paparella, Zikai Feng, Kwang J. Lee, Beatriz Blanco-Rodriguez et al. "Advanced Resistance Studies Identify Two Discrete Mechanisms in Staphylococcus aureus to Overcome Antibacterial Compounds that Target Biotin Protein Ligase". Antibiotics 9, n.º 4 (6 de abril de 2020): 165. http://dx.doi.org/10.3390/antibiotics9040165.
Texto completoTripathi, Rama P., Jyoti Pandey, Vandana Kukshal, Arya Ajay, Mridul Mishra, Divya Dube, Deepti Chopra, R. Dwivedi, Vinita Chaturvedi y Ravishankar Ramachandran. "Synthesis, in silico screening and bioevaluation of dispiro-cycloalkanones as antitubercular and mycobacterial NAD+-dependent DNA ligase inhibitors". MedChemComm 2, n.º 5 (2011): 378. http://dx.doi.org/10.1039/c0md00246a.
Texto completoRobert, Carine, Nidal E. Muvarak, Vu H. Duong, Maria R. Baer, Stephen B. Baylin y Feyruz Rassool. "Demethylating Agents Reprogram Myelodysplastic Syndrome and Leukemia Cells, Sensitizing Them To Poly-(ADP)-Ribose Polymerase Inhibitors". Blood 122, n.º 21 (15 de noviembre de 2013): 3778. http://dx.doi.org/10.1182/blood.v122.21.3778.3778.
Texto completoJo, Ukhyun, Yasuhisa Murai, Sirisha Chakka, Lu Chen, Ken Cheng, Junko Murai, Liton Kumar Saha, Lisa M. Miller Jenkins y Yves Pommier. "SLFN11 promotes CDT1 degradation by CUL4 in response to replicative DNA damage, while its absence leads to synthetic lethality with ATR/CHK1 inhibitors". Proceedings of the National Academy of Sciences 118, n.º 6 (3 de febrero de 2021): e2015654118. http://dx.doi.org/10.1073/pnas.2015654118.
Texto completoKeefe, Anthony D., Jeremy S. Disch, Jennifer Duffy, Esther C. Lee, Diana Gikunju, Betty Chan, Benjamin D. Levin et al. "Abstract 5346: Discovery of new targeted protein degraders using DNA-encoded chemistry". Cancer Research 83, n.º 7_Supplement (4 de abril de 2023): 5346. http://dx.doi.org/10.1158/1538-7445.am2023-5346.
Texto completoCabrera, Raninga, Khanna y Freire. "GSK3-β Stimulates Claspin Degradation via β-TrCP Ubiquitin Ligase and Alters Cancer Cell Survival". Cancers 11, n.º 8 (29 de julio de 2019): 1073. http://dx.doi.org/10.3390/cancers11081073.
Texto completoGu, Wenxin, Tiansheng Wang, Francois Maltais, Brian Ledford, Joseph Kennedy, Yunyi Wei, Christian H. Gross et al. "Design, synthesis and biological evaluation of potent NAD+-dependent DNA ligase inhibitors as potential antibacterial agents. Part I: Aminoalkoxypyrimidine carboxamides". Bioorganic & Medicinal Chemistry Letters 22, n.º 11 (junio de 2012): 3693–98. http://dx.doi.org/10.1016/j.bmcl.2012.04.037.
Texto completovon Klitzing, Christine, Florian Bassermann, Stephan W. Morris, Christian Peschel y Justus Duyster. "A Role for NIPA in DNA Damage Response." Blood 104, n.º 11 (16 de noviembre de 2004): 1265. http://dx.doi.org/10.1182/blood.v104.11.1265.1265.
Texto completoWergeland, Line, Kevin B. Spurgers, Eystein Oveland, Torill Høiby, Manel Cascallo, Tsuyoshi Honda, James B. Lorens, Guillermina Lozano, Timothy J. McDonnell y Bjorn T. Gjertsen. "Bcl-2 Protects against p53-Induced Apoptosis through Hdm2". Blood 112, n.º 11 (16 de noviembre de 2008): 5333. http://dx.doi.org/10.1182/blood.v112.11.5333.5333.
Texto completoPettersson, Susanne, Michael Kelleher, Emmanuelle Pion, Maura Wallace y Kathryn L. Ball. "Role of Mdm2 acid domain interactions in recognition and ubiquitination of the transcription factor IRF-2". Biochemical Journal 418, n.º 3 (25 de febrero de 2009): 575–85. http://dx.doi.org/10.1042/bj20082087.
Texto completoRowley, Roy y Jun Zhang. "Caffeine-Mediated Override of Checkpoint Controls: A Requirement for rhp6 (Schizosaccharomyces pombe)". Genetics 152, n.º 1 (1 de mayo de 1999): 61–71. http://dx.doi.org/10.1093/genetics/152.1.61.
Texto completoNichols, Gena J., Jerome Schaack y David A. Ornelles. "Widespread Phosphorylation of Histone H2AX by Species C Adenovirus Infection Requires Viral DNA Replication". Journal of Virology 83, n.º 12 (25 de marzo de 2009): 5987–98. http://dx.doi.org/10.1128/jvi.00091-09.
Texto completoSurivet, Jean-Philippe, Roland Lange, Christian Hubschwerlen, Wolfgang Keck, Jean-Luc Specklin, Daniel Ritz, Daniel Bur et al. "Structure-guided design, synthesis and biological evaluation of novel DNA ligase inhibitors with in vitro and in vivo anti-staphylococcal activity". Bioorganic & Medicinal Chemistry Letters 22, n.º 21 (noviembre de 2012): 6705–11. http://dx.doi.org/10.1016/j.bmcl.2012.08.094.
Texto completoR, Sri Dharani, Ranjitha R, Sripathi R, Ali Muhammad K S y Ravi S. "DOCKING STUDIES IN TARGET PROTEINS INVOLVED IN ANTIBACTERIAL ACTION MECHANISMS: ALKALOIDS ISOLATED FROM SCUTELLARIA GENUS". Asian Journal of Pharmaceutical and Clinical Research 9, n.º 5 (1 de septiembre de 2016): 121. http://dx.doi.org/10.22159/ajpcr.2016.v9i5.12693.
Texto completoYu, Duonan, Martin Carroll y Andrei Thomas-Tikhonenko. "p53 status dictates responses of B lymphomas to monotherapy with proteasome inhibitors". Blood 109, n.º 11 (1 de junio de 2007): 4936–43. http://dx.doi.org/10.1182/blood-2006-10-050294.
Texto completoLambert, Carsten, Tatjana Döring y Reinhild Prange. "Hepatitis B Virus Maturation Is Sensitive to Functional Inhibition of ESCRT-III, Vps4, and γ2-Adaptin". Journal of Virology 81, n.º 17 (6 de junio de 2007): 9050–60. http://dx.doi.org/10.1128/jvi.00479-07.
Texto completoDeng, Liang, Peihong Dai, Anthony Ciro, Donald F. Smee, Hakim Djaballah y Stewart Shuman. "Identification of Novel Antipoxviral Agents: Mitoxantrone Inhibits Vaccinia Virus Replication by Blocking Virion Assembly". Journal of Virology 81, n.º 24 (10 de octubre de 2007): 13392–402. http://dx.doi.org/10.1128/jvi.00770-07.
Texto completoWeber, Elisabeth, Ina Rothenaigner, Stefanie Brandner, Kamyar Hadian y Kenji Schorpp. "A High-Throughput Screening Strategy for Development of RNF8-Ubc13 Protein–Protein Interaction Inhibitors". SLAS DISCOVERY: Advancing the Science of Drug Discovery 22, n.º 3 (13 de diciembre de 2016): 316–23. http://dx.doi.org/10.1177/1087057116681408.
Texto completo